ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

British Journal of Dermatology

British Journal of Dermatology

Volume 96 Issue 1, Pages 71 - 73

Published Online: 29 Jul 2006

Journal compilation © 2010 British Association of Dermatologists



< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: PDF (Size: 527K)  | Related Articles | Citation Tracking

A double-blind trial of 0.05% clobetasol proprionate in the treatment of vitiligo
ROGER CLAYTON 1
  1 Department of Dermatology, St Mary's Hospital, London W2
Copyright 1977 British Association of Dermatologists

ABSTRACT

AbstractREFERENCES

0.05% clobetasol proprionate (CP) in its proprietary cream base was significantly superior to the cream base alone in the treatment of vitiligo. Twelve of twenty-three patients partially repigmented during 4 months' treatment with CP. All patients showed dermal atrophy with the CP.


Accepted for publication 2 July 1976

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1365-2133.1977.tb05188.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now
Sign Up Now
Wiley Medical Twitter